People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| PBS Biotech, Inc. | — | Biotechnology | Series B | $43.2M | $55.7M | 2024 |
Matt Croughan at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Matt Croughan on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Brian Lee | 1 | 19 |
| Dennis Fenton | 1 | 4 |
| Bryan Poltilove | 1 | 3 |
| Daniel Friedman | 1 | 3 |
| Leland Foster | 1 | 1 |
| Jung Lim | 1 | 1 |
| Xiaoshen (Jerry) Liao | 1 | 1 |
| Xiaoshen Liao | 1 | 1 |
| Nelson Bermudez | 1 | 1 |
| Terrell Mathews | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.